A Simple Key For ABBV-744 BRD4 inhibition in cancer cell lines Unveiled
In Section C, individuals will acquire ABBV-744 and oral navitoclax. In Segment D, members will receive ABBV-744 and ruxolitinib. Individuals will get treatment till ailment progression or even the members are unable to tolerate the study drugs.Ubiquitin-linked proteins that regulate the stability of essential Tremendous enhancer-mediated proteins